No black box warning on record for Kadcyla
As of the latest FDA labeling reviewed, Kadcyla (ADO-TRASTUZUMAB EMTANSINE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Kadcyla medicine page for the complete safety profile.